Shandong Sinobioway Biomedicine Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 275.53 million compared to CNY 315.79 million a year ago. Revenue was CNY 275.53 million compared to CNY 315.79 million a year ago.

Net income was CNY 64.45 million compared to CNY 347.45 million a year ago. Basic earnings per share from continuing operations was CNY 0.0977 compared to CNY 0.5267 a year ago. Diluted earnings per share from continuing operations was CNY 0.0977 compared to CNY 0.5267 a year ago.